| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 16,339,000 | 14,983,000 | | Cost of Revenue | 1,776,000 | 2,389,000 | | | Gross Profit | 14,563,000 | 12,594,000 | | | Operating Expenses | | Research Development |
-
| 190,000 | | Selling General and Administrative | 10,436,000 | 7,203,000 | | Non Recurring | 664,000 | 404,000 | | Others | 613,000 | 510,000 | | | | Total Operating Expenses |
-
| 8,307,000 | | | | Operating Income or Loss | 2,850,000 | 4,287,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| | Earnings Before Interest And Taxes | 2,850,000 | 4,287,000 | | Interest Expense | 911,000 | 1,062,000 | | Income Before Tax | 1,939,000 | 3,225,000 | | Income Tax Expense | 497,000 | 998,000 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 1,442,000 | 2,227,000 | | | Non-recurring Events | | Discontinued Operations | 3,000 | (8,000) | | Extraordinary Items | (26,000) | (180,000) | | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 1,419,000 | 2,039,000 | | Preferred Stock And Other Adjustments | (33,000) |
-
| | | Net Income Applicable To Common Shares | $1,386,000 | $2,039,000 |
|
0.43% Nasdaq 
Income Statement
